ArticleBMC cancer2023

Polymorphism at codon 31 of CDKN1A (p21) as a predictive factor for bevacizumab therapy in glioblastoma multiforme.

Wen-Yu Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.